Estimates of How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization

How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization? This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compare… kffmatthewm KFF

...most, but not all, people will still have free access. Still, the cost of purchasing vaccines for the population is likely to rise on a per dose basis, though the extent to which it affects total health spending is dependent on vaccine uptake and any negotiated discounts, among other factors.

....

While the commercial prices for COVID-19 vaccines are not yet known, both Pfizer and Moderna have signaled likely ranges that are three to four times greater than the pre-purchased federal price for the bivalent booster. In a recent investor call, Pfizer indicated that it expected a commercial price per dose for its vaccine to be between $110 and $130. Moderna has suggested a commercial price between $82 and $100 per dose. If equal amounts of each manufacturer’s vaccine are used, the average commercial price per dose would range from a low of $96 to a high of $115. This range is 3 to 4 times greater than the weighted average price per dose paid by the federal government for Moderna and Pfizer bivalent doses ($28.90).

...